UK 432097

• CAT Number: I009224
• CAS Number: 380221-63-6
• Molecular Formula: C40H47N11O6
• Molecular Weight: 777.887
• Purity: ≥95%
• Target: adenosine A2A agonist
• Solubility: Soluble in DMSO
• Storage: 0 - 4 °C for short term, or -20 °C for long term
• IUPAC Name: 6-(2,2-diphenylethylamino)-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]-N-[2-[(1-pyridin-2-ylpiperidin-4-yl)carbamoylamino]ethyl]purine-2-carboxamide
• InChI: InChI=1S/C40H47N11O6/c1-2-41-37(54)33-31(52)32(53)39(57-33)51-24-46-30-34(45-23-28(25-11-5-3-6-12-25)26-13-7-4-8-14-26)48-35(49-36(30)51)38(55)43-19-20-44-40(56)47-27-16-21-50(22-17-27)29-15-9-10-18-42-29/h3-15,18,24,27-28,31-33,39,52-53H,2,16-17,19-23H2,1H3,(H,41,54)(H,43,55)(H2,44,47,56)(H,45,48,49)/t31-,32+,33-,39+/m0/s1
• InChIKey: ZOTHAEBAWXWVID-HXEFRTELSA-N
• SMILES: CCNC(=O)C1C(C(C(O1)N2C=NC3=C2N=C(N=C3NCC(C4=CC=CC=C4)C5=CC=CC=C5)C(=O)NCCNC(=O)NC6CCN(CC6)C7=CC=CC=N7)O)O

UK 432097 (CAT: I009224) is a potent adenosine A2A receptor agonist with potential applications in the treatment of chronic obstructive pulmonary disease (COPD). By selectively targeting the adenosine A2A receptor, UK 432097 exhibits pharmacologic action by promoting bronchodilation and exerting anti-inflammatory effects in the lungs. This compound specifically acts on the adenosine A2A receptor, a G-protein coupled receptor involved in regulating inflammation and immune responses. The therapeutic potential of UK 432097 lies in its ability to improve lung function and reduce inflammation, making it a promising candidate for the management of COPD and potentially other respiratory conditions.

Reference

1:Xu F, Wu H, Katritch V, Han GW, Jacobson KA, Gao ZG, Cherezov V, Stevens RC. Structure of an agonist-bound human A2A adenosine receptor. Science. 2011 Apr 15;332(6027):322-7. doi: 10.1126/science.1202793. PubMed PMID: 21393508; PubMed Central PMCID: PMC3086811.
2: Jones RM, Harrison A. A new methodology for predicting human pharmacokinetics for inhaled drugs from oratracheal pharmacokinetic data in rats. Xenobiotica. 2012 Jan;42(1):75-85. doi: 10.3109/00498254.2011.626465. PubMed PMID: 22077102.
3: Mantell S, Jones R, Trevethick M. Design and application of locally delivered agonists of the adenosine A(2A) receptor. Expert Rev Clin Pharmacol. 2010 Jan;3(1):55-72. doi: 10.1586/ecp.09.57. PubMed PMID: 22111533.